ACO Financial Arrangements Sample Clauses

The ACO Financial Arrangements clause defines how financial transactions and responsibilities are managed within an Accountable Care Organization (ACO) agreement. It typically outlines the methods for distributing shared savings, handling losses, and allocating costs among participating providers or entities. For example, it may specify how payments from payers are divided or how financial risk is shared if expenditures exceed targets. The core function of this clause is to ensure transparency and fairness in financial dealings, thereby reducing disputes and aligning incentives among ACO participants.
ACO Financial Arrangements. A. The ACO shall not condition a Participant Provider’s or Preferred Provider’s participation in the Model, directly or indirectly, on referrals of items or services provided to Beneficiaries who are not aligned to the ACO. B. The ACO shall not require, and shall ensure that its Participant Providers and Preferred Providers do not require, that REACH Beneficiaries be referred only to Participant Providers or Preferred Providers or to any other provider or supplier. This prohibition shall not apply to referrals made by employees or contractors who are operating within the scope of their employment or contractual arrangement with the employer or contracting entity, provided that the employees and contractors remain free to make referrals without restriction or limitation if a REACH Beneficiary expresses a preference for a different provider or supplier, or the referral is not in the REACH Beneficiary's best medical interests in the judgment of the referring party. C. The ACO shall not condition the eligibility of an individual or entity to be a Participant Provider or Preferred Provider on the individual’s or entity’s offer or payment of cash or other remuneration to the ACO or any other individual or entity. D. The ACO shall ensure that no party to an ACO financial arrangement gives or receives remuneration in return for, or to induce or reward, any Federal health care program referrals or business generated outside of the Model, and the compensation does not induce either party or other providers or suppliers to furnish medically unnecessary items or services, or to reduce or limit Medically Necessary items or services to any Beneficiary. E. The ACO shall not take, and shall ensure that its Participant Providers and Preferred Providers do not take, any action to limit the ability of a Participant Provider or Preferred Provider to make decisions in the best interests of a Beneficiary, including the selection of devices, supplies and treatments used in the care of the Beneficiary. F. The ACO shall notify CMS within 15 Days after becoming aware that the ACO, a Participant Provider, or a Preferred Provider is under investigation or has been sanctioned by the government or any licensing authority (including, without limitation, the imposition of program exclusion, debarment, civil monetary penalties, corrective action plans, and revocation of Medicare billing privileges). If the ACO, a Participant Provider, or a Preferred Provider is under investigation or has ...

Related to ACO Financial Arrangements

  • Financial Arrangements The Commonwealth will provide an estimated total financial contribution to the States of up to $9.5 billion (GST exclusive) in respect of this Agreement, as set out in Part 5 – Financial Arrangements.

  • Special Arrangements Fees for activities of a non-recurring nature such as reorganizations, and/or preparation of special reports will be subject to negotiation.

  • Additional Arrangements The UVMP in Košice can offer to students, within its own accommodation capacities, an accommodation in its own facilities for the respective academic year. The accommodation fee and conditions of providing the accommodation are in full competence of the UVMP.

  • Transitional Arrangements 1. Subject to the provisions of paragraphs 2, 3 and 4, no Member shall be obliged to apply the provisions of this Agreement before the expiry of a general period of one year following the date of entry into force of the WTO Agreement. 2. A developing country Member is entitled to delay for a further period of four years the date of application, as defined in paragraph 1, of the provisions of this Agreement other than Articles 3, 4 and 5. 3. Any other Member which is in the process of transformation from a centrally-planned into a market, free-enterprise economy and which is undertaking structural reform of its intellectual property system and facing special problems in the preparation and implementation of intellectual property laws and regulations, may also benefit from a period of delay as foreseen in paragraph 2. 4. To the extent that a developing country Member is obliged by this Agreement to extend product patent protection to areas of technology not so protectable in its territory on the general date of application of this Agreement for that Member, as defined in paragraph 2, it may delay the application of the provisions on product patents of Section 5 of Part II to such areas of technology for an additional period of five years. 5. A Member availing itself of a transitional period under paragraphs 1, 2, 3 or 4 shall ensure that any changes in its laws, regulations and practice made during that period do not result in a lesser degree of consistency with the provisions of this Agreement.

  • Business Arrangements Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, neither the Company nor any of its subsidiaries has granted rights to develop, manufacture, produce, assemble, distribute, license, market or sell its products to any other person and is not bound by any agreement that affects the exclusive right of the Company or such subsidiary to develop, manufacture, produce, assemble, distribute, license, market or sell its products.